Literature DB >> 7746463

ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val-->Ile mutated families.

B Nacmias1, S Latorraca, P Piersanti, P Forleo, S Piacentini, L Bracco, L Amaducci, S Sorbi.   

Abstract

Recent studies have shown a genetic association of the apolipoprotein E (ApoE) epsilon 4 allele with late onset familial and sporadic Alzheimer's disease (AD). In this study we analysed the possible association of the genetic polymorphism of the ApoE gene with age of onset in Italian familial Alzheimer's disease (FAD) families including two early onset familial Alzheimer's (EOFAD) families with the APP717 Val-->Ile mutation in the amyloid precursor protein (APP) gene on chromosome 21. In none of the FAD families analysed was there a significant effect of the ApoE genotype on the age of onset with the exception of one of the two mutated EOFAD families in which the epsilon 2 allele delayed the age of onset.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746463     DOI: 10.1016/0304-3940(94)11100-w

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.

Authors:  Joseph H Lee; Sandra Barral; Rong Cheng; Inara Chacon; Vincent Santana; Jennifer Williamson; Rafael Lantigua; Martin Medrano; Ivonne Z Jimenez-Velazquez; Yaakov Stern; Benjamin Tycko; Ekaterina Rogaeva; Yosuke Wakutani; Toshitaka Kawarai; Peter St George-Hyslop; Richard Mayeux
Journal:  Neurogenetics       Date:  2007-10-17       Impact factor: 2.660

Review 2.  Dancing in the dark? The status of late-onset Alzheimer's disease genetics.

Authors:  L Bertram; R E Tanzi
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

3.  No founder effect in three novel Alzheimer's disease families with APP 717 Val-->Ile mutation. Clerget-darpoux. French Alzheimer's Disease Study Group.

Authors:  D Campion; A Brice; D Hannequin; F Charbonnier; B Dubois; C Martin; A Michon; C Penet; M Bellis; A Calenda; M Martinez; Y Agid; F Clerget-Darpoux; T Frebourg
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

Review 4.  Of replications and refutations: the status of Alzheimer's disease genetic research.

Authors:  L Bertram; R E Tanzi
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

5.  Genetic studies in Alzheimer's disease.

Authors:  Ya-Ping Tang; Elliot S Gershon
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

6.  Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.

Authors:  Grace M Lloyd; Jorge A Trejo-Lopez; Yuxing Xia; Karen N McFarland; Sarah J Lincoln; Nilüfer Ertekin-Taner; Benoit I Giasson; Anthony T Yachnis; Stefan Prokop
Journal:  Acta Neuropathol Commun       Date:  2020-03-12       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.